{"id":14098,"date":"2023-10-20T12:31:03","date_gmt":"2023-10-20T10:31:03","guid":{"rendered":"https:\/\/tecnologiehosting.it\/?p=14098"},"modified":"2026-01-28T12:10:47","modified_gmt":"2026-01-28T11:10:47","slug":"braindtech-brain-code-revolutionize-detection-traumatic-brain-injury","status":"publish","type":"post","link":"https:\/\/bio4dreams.com\/en\/braindtech-brain-code-revolutionize-detection-traumatic-brain-injury\/","title":{"rendered":"Brain Code, Inc to revolutionize the detection of traumatic brain injury"},"content":{"rendered":"\n

We are excited to announce that BrainDTech<\/strong>, one of the promising entities incubated and affiliated by Bio4Dreams, has established a joint venture with Great Product Ventures<\/strong> to found Brain Code<\/a> Inc<\/strong>. This strategic collaboration aims to revolutionize the early diagnosis of traumatic brain injuries through the use of non-invasive biomarkers.<\/p>\n\n\n

\n
\"\"<\/figure>\n<\/div>\n\n\n

Brain Code<\/h2>\n\n\n\n

The JV, headquartered in Cambridge MA with a CLIA-certified lab facility in Dallas, TX, will deliver fast and reliable tests to monitor brain inflammation as it develops in complex brain diseases such as Traumatic Brain Injury, brain inflammation and other critical neurodegenerative diseases in order to support crucial and time-sensitive decisions regarding detection and therapy.<\/p>\n\n\n\n

The company, endowed by BrainDTech\u2019s proprietary microfluidic platform MicroCATCH and accelerated by one of the most innovative venture development firms in the U.S. and Europe, will also take advantage of the industrial expertise of Brian Meshkin, Board Member and Partner of the Company is an Award-Winning Technology Entrepreneur & Executive who has led some of the fastest growing technology companies in North America in the field of precision medicine.<\/p>\n\n\n\n

\n

\u201cThe signing of this JV represents for BrainDTech an important milestone in its global expansion strategy as we strive to deliver a revolution in precision medicine biomarker development for complex disease identification and monitoring.\u201d<\/em><\/p>\nFabio Bianco<\/strong>, CEO of BrainDTech<\/cite><\/blockquote>\n\n\n\n

At least 2.8 million Americans sustain traumatic brain injuries in the United States every year. Traumatic Brain Injury can not only lead to lifelong damage for the individual effected but can mask itself during the first 48 hours. Most TBI victims \u201cappear\u201d to recover within 48 hours using standard testing, only to suffer death or debilitating injury after the 48-hour period. BrainCode solve this problem in 20 minutes.<\/p>\n\n\n\n

\n

“Doing well by doing good has always been our motto […] The technology developed by BrainDTech over the last many years is going to be very impactful in people\u2019s lives. We see MicroCATCH having a huge benefit in the early diagnosis of Traumatic Brain Injury in Athletes, our Military, and others. […] Every First Responder should have a MicroCATCH onboard.\u201d<\/em><\/p>\nJonathan Ramaci<\/strong>, CEO of both Great Product and Brain Code<\/cite><\/blockquote>\n\n\n\n

MicroCATCH<\/h2>\n\n\n\n

The MicroCATCH Platform is a portable, IoT enabled device capable of testing a various, noninvasive body fluids and precisely detecting certain biomarkers within minutes. These biomarkers have undergone years of scientific rigor and can be used to determine TBI, Dementia and other diseases of the brain.<\/p>\n\n\n\n

Congratulations to BrainDTech and everyone involved in this extraordinary initiative. We will continue to support BrainDTech with dedication, as well as all the other entities within our network, in the development of meaningful innovative solutions in the field of Life Sciences.<\/p>\n\n\n\n

\ud83d\udcc4 Press release<\/a><\/p>\n\n\n\n

News<\/strong><\/p>\n\n\n\n